Zelnorm (tegaserod) / Novartis 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zelnorm (tegaserod) / Novartis
NCT00511771: A Treatment Investigational New Drug (tIND) Program of Tegaserod in Women With Irritable Bowel Syndrome With Constipation or With Chronic Idiopathic Constipation

No Longer Available
N/A
US
Tegaserod, Zelnorm
Novartis
Irritable Bowel Syndrome With Constipation, Chronic Idiopathic Constipation
 
 

Download Options